"The upside is probably limited unless again the liquidity flows and the momentum continues on the market."

"From a fundamental perspective, you could accumulate, I would be overly aggressive on the stock", Sajiv Dhawan said.

In a chat with ET Now, Sajiv Dhawan, MD, JV Capital Services, shares his views on pharma sector.

"We focus more on the DVR because that is just a cheaper way to approach the stock. You buy at Rs 150 to 155 levels", Sajiv Dhawan said.

The simple thing is that 230 has got that potential to give you that 10-15%. Fundamentals are clearly known, if the European situation gets...

ITC may have another 5-10% upside based on momentum, but fundamentally the prices reflect the current fundamental value.

Buy with dips until the momentum is broken but for sure, short-term outlook is still reasonably positive for these stocks.

In an interview with ET Now, Sajiv Dhawan, MD, JV Capital Services, shares his views on the markets and various stocks. Excerpts:

From an investor’s perspective, IT is not the best sector at the moment because a lot of the upside is already factored in and is reflected...

There are no good calls at the moment because too many people stuck with these stocks at every significant rally in the stock price.

At 650-660 levels we are getting Mahindra & Mahindra at a good price with a lot of bad news factored in. So, that would be a stock which ca...

Most of the times these stocks will trade in a range. It is not a sector that I say would outperform even in the next year or so.

If we are very optimistic, it is a great company and a great stock. If we are looking two-three years, the stock has a huge potential.

"It is not going back to 4700-4800 in a hurry but a couple of percentage points here and there is very likely up or down over the next few ...

"From an investment perspective, I would look to buy on the dips and certainly if I had a patience stance, then remain invested and maybe w...

Sajiv Dhawan, MD, JV Capital Services talks to ET Now about Infra stocks & OMCs.

ET Now caught up with Sajiv Dhawan, MD, JV Capital Services, to find out his take on Nifty.